Structure of unliganded HIV-1 reverse transcriptase at 2.7 Å resolution: Implications of conformational changes for polymerization and inhibition mechanisms

Structure

Volumn 4, Issue 7, 1996, Pages 853-860

  Hsiou, Y ^a   Ding, J ^a   Das, K ^a   Clark Jr , A D ^a   Hughes, S H ^b   Arnold, E ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AIDS; drug design; mechanism of polymerization; non nucleoside inhibition mechanism; polymerase structure

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030586090     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(96)00091-3     Document Type: Article

References (32)

1. Larder, B.A. (1993). Inhibitors of HIV reverse transcriptase as antiviral agents and drug resistance. In Reverse Transcriptase. (Skalka, A.M. & Goff, S.P., eds), pp. 205-222, Cold Spring Harbor Laboratory Press, New York.
2. Tantillo, C., et al., & Arnold, E. (1994). Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase: implications for mechanisms of drug inhibition and resistance. J. Mol. Biol. 243, 369-387.
3. De Clercq, E. (1995). Toward improved anti-HIV chemotherapy: Therapeutic strategies for intervention with HIV infections. J. Med. Chem. 38, 2491-2517.
4. Arnold, E., Das, K., Ding, J., Yadav, P.N.S., Hsiou, Y., Boyer, P.L. & Hughes, S.H. (1996). Targeting HIV reverse transcriptase for anti-AIDS drug design. Drug Design and Discovery. 13, 29-47.
5. Kohlstaedt, L.A., Wang, J., Friedman, J.M., Rice, P.A. & Steitz, T.A. (1992). Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256, 1783-1790.
6. Smerdon, S.J., et al., & Steitz, T.A. (1994). Structure of the binding site for non-nucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 3911-3915.
7. Ren, J., et al., & Stammers, D. (1995). High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat. Struct. Biol. 2, 293-302.
8. Ding, J., et al., & Arnold, E. (1995). Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor α-APA R 95845 at 2.8 Å resolution. Structure 3, 365-379.
9. Ding, J., et al., & Arnold, E. (1995). Structure of HIV-1 RT/TIBO R 86183 reveals similarity in the binding of diverse non-nucleoside inhibitors. Nat. Struct. Biol. 2, 407-415.
10. Ren, J., et al., & Stuart, D. (1995). The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design. Structure 3, 915-926.
11. Jacobo-Molina, A., et al., & Arnold, E. (1993). Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90, 6320-6324.
12. Rodgers, D.W., et al., & Harrison, S.C. (1995). The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92, 1222-1226.
13. Esnouf, R., Ren, J., Ross, R., Jones, Y., Stammers, D. & Stuart, D. (1995). Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Nat. Struct. Biol. 2, 303-308.
14. Georgiadis, M.M., Jessen, S.M., Ogata, C.M., Telesnitsky, A., Goff, S.P. & Hendrickson, W.A. (1995). Mechanistic implications from the structure of a catalytic fragment of Moloney murine leukemia virus reverse transcriptase. Structure 3, 879-892.
15. Jäger, J., Smerdon, S.J., Wang, J., Boisvert, D.C. & Steitz, T.A. (1994). Comparison of three different crystal forms shows HIV-1 reverse transcriptase displays an internal swivel motion. Structure 2, 869-876.
16. Spence, R.A., Kati, W.M., Anderson, K.S. & Johnson, K.A. (1995). Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors. Science 267, 988-993.
17. Rittinger, K., Divita, G. & Goody, R. (1995). Human immunodeficiency virus reverse transcriptase substrate-induced conformational changes and the mechanism of inhibition by non-nucleoside inhibitors. Proc. Natl. Acad. Sci. USA 92, 8046-8049.
18. Debyser, Z., et al., & De Clercq, E. (1991). An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk][1,4]benzodiazepinone-2(1H)-one and -thione derivatives. Proc. Natl. Acad. Sci. USA 88, 1451-1455.
19. Palaniappan, C., Fay, P.J. & Bambara, R.A. (1995). Nevirapine alters the cleavage specificity of ribonuclease H of human immunodeficiency virus 1 reverse transcriptase. J. Biol. Chem. 270, 4861-4869.
20. Boyer, P.L., Ferris, A.L. & Hughes, S.H. (1992). Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66, 1031-1039.
21. Boyer, P.L., Ferris, A.L. & Hughes, S.H. (1992). Mutational analysis of the fingers domain of human immunodeficiency virus type-1 reverse transcriptase. J. Viro. 66, 7533-7537.
22. Boyer, P.L., et al., & Hughes, S.H. (1994). Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase. J. Mol. Biol. 243, 472-483.
23. Kleim, J.-P., et al., & Riess, G. (1996). Selective pressure of a quinoxaline class non-nucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT inhibitor specific (RT L74• V/I, V75• L/I) HIV-1 mutants. Proc. Natl. Acad. Sci. USA 93, 34-38.
24. Clark, A.D., Jr., Jacobo-Molina, A., Clark, P., Hughes, S.H. & Arnold, E. (1995). Crystallization of human immunodeficiency virus type-1 reverse transcriptase with and without nucleic acid substrates, inhibitors and an antibody Fab fragment. In Methods in Enzymology. (Campbell, J.L., ed.), pp. 171-185, Academic Press, New York.
25. Teng, T.Y. (1990). Mounting of crystals for macromolecular crystallography in a free-standing thin film. J. Appl. Cryst. 24, 387-391.
26. Rodgers, D.W. (1994). Cryocrystallography. Structure 2, 1135-1140.
27. Otwinowski, Z. (1993). Oscillation Data Reduction Program. In Proceeding of the CCP4 Study Weekend: Data Collection and Processing. (Sawyer, L., Issacs N., Bailey, S., eds), pp 55-62, SERC Daresbury Laboratory, UK.
28. Miner, W. (1993). XDISPLAYF Program, Purdue University.
29. Collaborative Computational Project, No. 4. (1994). The CCP4 Suite: Programs for Protein Crystallography. Acta Cryst. D 50, 760-763.
30. Brünger, A.T. (1993). X-PLOR Manual Version 3.1: A system for X-ray crystallography and NMR. Yale University Press, New Haven and London.
31. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Cryst. A 47, 110-119.
32. Carson, M. (1987). Ribbon models of macromolecules. J. Mol. Graphics 5, 103-106.